• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Quick Take: Differing risk of mortality in trauma patients with stab wounds to the torso: treating hospital matters

byAliya Ramjaun
September 10, 2019
in Emergency, Surgery
Reading Time: 2 mins read
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery
Share on FacebookShare on Twitter

Stab wounds are managed operatively and, in select cases, non-operatively, depending on a patient’s hemodynamic stability, the anatomic location of the stabbing, and whether the patient demonstrates peritoneal signs. While some studies have demonstrated that patients with injuries associated with high mortality are more likely to achieve better survival and functional outcomes at level I centers, a more recent analysis found no difference in mortality for patients with penetrating trauma presenting to a level I versus level II center. In this retrospective cohort study, 17,245 adult patients admitted to an American College of Surgeons-verified level I or II center after a torso stab wound (2010-2016) were followed up to compare time to surgical intervention and mortality rates. Of the patients included in the study, 73.2% were treated at level I centers. Patients treated at either level I or level II centers had comparable injury severity scores. Researchers found that level I centers had a higher rate of laparotomy (25.5% vs. 21.4%, p<0.001) and shorter time to laparotomy (p=0.01). There was no difference in time to thoracotomy (p=0.86). Rates of mortality after thoracotomy, however, were decreased in patients treated at level I centers (p=0.04). Overall, patients treated at level I centers had a decreased risk of mortality when compared to patients at level II centers (OR 0.67, 95% CI 0.54 to 0.85, p<0.001). This study therefore shows that patients with torso stab wounds treated at level I centers have a lower risk of mortality and decreased time to laparotomy.

Click to read the study in JAMA Surgery

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

Ocular trauma may be a predictor of mortality in geriatric patients

Bedside parameters may help predict chronic post-traumatic head and neck pain

Tags: penetrating traumastab woundthoracotomytraumatrauma center
Previous Post

N95 masks may have similar efficacy to medical masks for influenza prevention

Next Post

#VisualAbstract: Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission

RelatedReports

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome
Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Chronic Disease

Ocular trauma may be a predictor of mortality in geriatric patients

June 2, 2025
Chronic Disease

Bedside parameters may help predict chronic post-traumatic head and neck pain

May 25, 2025
Chronic Disease

Gender is not a mediating factor in the relationship between pain and post traumatic stress disorder

May 26, 2024
Next Post
#VisualAbstract: Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission

#VisualAbstract: Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission

Quick Take: Association of Cereal, Gluten, and Dietary Fiber Intake With Islet Autoimmunity and Type 1 Diabetes

Quick Take: Gluten does not induce gastrointestinal symptoms in healthy volunteers

#VisualAbstract: Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES)

#VisualAbstract: Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES)

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
  • 2 Minute Medicine Rewind September 28, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.